Literature DB >> 19158244

Peptidylproline cis-trans-isomerase Pin1 interacts with human T-cell leukemia virus type 1 tax and modulates its activation of NF-kappaB.

Jean-Marie Peloponese1, Junichiro Yasunaga, Takao Kinjo, Koichi Watashi, Kuan-Teh Jeang.   

Abstract

Human T-cell leukemia virus type 1 (HTLV-1) is an oncogenic retrovirus etiologically causal of adult T-cell leukemia (ATL). The virus encodes a Tax oncoprotein that functions in transcriptional regulation, cell cycle control, and transformation. ATL is a highly virulent cancer that is resistant to chemotherapeutic treatments. To understand this disease better, it is important to comprehend how HTLV-1 promotes cellular growth and survival. Tax activation of NF-kappaB is important for the proliferation and transformation of virus-infected cells. We show here that prolyl isomerase Pin1 is over expressed in HTLV-1 cell lines; Pin1 binds Tax and regulates Tax-induced NF-kappaB activation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19158244      PMCID: PMC2655545          DOI: 10.1128/JVI.01824-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  73 in total

1.  The N-terminus of rodent and human MAD1 confers species-specific stringency to spindle assembly checkpoint.

Authors:  K Haller; K V Kibler; T Kasai; Y-H Chi; J-M Peloponese; V S R K Yedavalli; K-T Jeang
Journal:  Oncogene       Date:  2006-04-06       Impact factor: 9.867

2.  The retroviral oncoprotein Tax targets the coiled-coil centrosomal protein TAX1BP2 to induce centrosome overduplication.

Authors:  Yick-Pang Ching; Shing-Fai Chan; Kuan-Teh Jeang; Dong-Yan Jin
Journal:  Nat Cell Biol       Date:  2006-06-11       Impact factor: 28.824

Review 3.  Modulation of nuclear factor-kappaB by human T cell leukemia virus type 1 Tax protein: implications for oncogenesis and inflammation.

Authors:  Jean-Marie Peloponese; Man Lung Yeung; Kuan-Teh Jeang
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 4.  Nuclear factor-kappaB in cancer development and progression.

Authors:  Michael Karin
Journal:  Nature       Date:  2006-05-25       Impact factor: 49.962

5.  Site-specific phosphorylation differentiates active from inactive forms of the human T-cell leukemia virus type 1 Tax oncoprotein.

Authors:  Sarah S Durkin; Michael D Ward; Kimberly A Fryrear; O John Semmes
Journal:  J Biol Chem       Date:  2006-08-21       Impact factor: 5.157

Review 6.  Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation.

Authors:  Masao Matsuoka; Kuan-Teh Jeang
Journal:  Nat Rev Cancer       Date:  2007-04       Impact factor: 60.716

7.  Coiled-coil motif as a structural basis for the interaction of HTLV type 1 Tax with cellular cofactors.

Authors:  A C Chun; Y Zhou; C M Wong; H F Kung; K T Jeang; D Y Jin
Journal:  AIDS Res Hum Retroviruses       Date:  2000-11-01       Impact factor: 2.205

Review 8.  Pin1 in Alzheimer's disease: multiple substrates, one regulatory mechanism?

Authors:  Martin Balastik; Jormay Lim; Lucia Pastorino; Kun Ping Lu
Journal:  Biochim Biophys Acta       Date:  2007-01-23

9.  HTLV-1 Tax: centrosome amplification and cancer.

Authors:  Anne Pumfery; Cynthia de la Fuente; Fatah Kashanchi
Journal:  Retrovirology       Date:  2006-08-09       Impact factor: 4.602

10.  Inactivation of tumor suppressor Dlg1 augments transformation of a T-cell line induced by human T-cell leukemia virus type 1 Tax protein.

Authors:  Kojiro Ishioka; Masaya Higuchi; Masahiko Takahashi; Sakiko Yoshida; Masayasu Oie; Yuetsu Tanaka; Sugata Takahashi; Li Xie; Patrick L Green; Masahiro Fujii
Journal:  Retrovirology       Date:  2006-10-17       Impact factor: 4.602

View more
  20 in total

Review 1.  NF-κB as a target for oncogenic viruses.

Authors:  Shao-Cong Sun; Ethel Cesarman
Journal:  Curr Top Microbiol Immunol       Date:  2011       Impact factor: 4.291

2.  The cellular peptidyl-prolyl cis/trans isomerase Pin1 regulates reactivation of Kaposi's sarcoma-associated herpesvirus from latency.

Authors:  Jonathan Guito; Aileen Gavina; Diana Palmeri; David M Lukac
Journal:  J Virol       Date:  2013-10-30       Impact factor: 5.103

3.  TCF1 and LEF1 act as T-cell intrinsic HTLV-1 antagonists by targeting Tax.

Authors:  Guangyong Ma; Jun-ichirou Yasunaga; Hirofumi Akari; Masao Matsuoka
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

Review 4.  Human T-lymphotropic virus proteins and post-translational modification pathways.

Authors:  Carlo Bidoia
Journal:  World J Virol       Date:  2012-08-12

Review 5.  Prolyl isomerase Pin1 as a molecular switch to determine the fate of phosphoproteins.

Authors:  Yih-Cherng Liou; Xiao Zhen Zhou; Kun Ping Lu
Journal:  Trends Biochem Sci       Date:  2011-08-17       Impact factor: 13.807

Review 6.  Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: viral infectivity, Tax, HBZ and therapy.

Authors:  M Matsuoka; K-T Jeang
Journal:  Oncogene       Date:  2010-11-29       Impact factor: 9.867

7.  Ubiquitin-specific peptidase 20 targets TRAF6 and human T cell leukemia virus type 1 tax to negatively regulate NF-kappaB signaling.

Authors:  Junichiro Yasunaga; Frank C Lin; Xiongbin Lu; Kuan-Teh Jeang
Journal:  J Virol       Date:  2011-04-27       Impact factor: 5.103

8.  Pin1 interacts with the Epstein-Barr virus DNA polymerase catalytic subunit and regulates viral DNA replication.

Authors:  Yohei Narita; Takayuki Murata; Akihide Ryo; Daisuke Kawashima; Atsuko Sugimoto; Teru Kanda; Hiroshi Kimura; Tatsuya Tsurumi
Journal:  J Virol       Date:  2012-12-05       Impact factor: 5.103

9.  HTLV-1 bZIP factor protein targets the Rb/E2F-1 pathway to promote proliferation and apoptosis of primary CD4(+) T cells.

Authors:  A Kawatsuki; J-I Yasunaga; Y Mitobe; P L Green; M Matsuoka
Journal:  Oncogene       Date:  2016-01-25       Impact factor: 9.867

Review 10.  The isomerase PIN1 controls numerous cancer-driving pathways and is a unique drug target.

Authors:  Xiao Zhen Zhou; Kun Ping Lu
Journal:  Nat Rev Cancer       Date:  2016-06-03       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.